Sankala Group’s CVS Health CVS Stock Holding History

Sankala Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.9K	Buy	357 +7	+2%	+$625	0.02%	289
2026 Q1	$24.9K	Hold	350	–	–	0.02%	297
2025 Q4	$28K	Buy	+350	New	+$27.6K	0.02%	284

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sankala Group's CVS Position: Q2 2026 in Review

Sankala Group increased its CVS Health (CVS) stake by 2% in Q2 2026, buying an estimated $625 and bringing the position to 357 shares worth $33.9K. The position accounts for 0.02% of the portfolio, ranked #289.

Sankala Group first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Sankala Group held 357 shares of CVS Health worth $33.9K as of Q2 2026.
Sankala Group bought 7 CVS Health shares in Q2 2026, an estimated $625.
CVS Health made up 0.02% of Sankala Group's portfolio in Q2 2026, its #289 holding.
Sankala Group first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.